A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma.
第一作者:
Wan-Hong,Zhao
第一单位:
Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West 5th Road, Xi'an, 710004, ShaanXi, China.
作者:
主题词
青少年(Adolescent);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);B细胞成熟抗原(B-Cell Maturation Antigen);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);多发性骨髓瘤(Multiple Myeloma);缓解诱导(Remission Induction);青年人(Young Adult)
DOI
10.1186/s13045-018-0681-6
PMID
30572922
发布时间
2020-03-09
- 浏览25
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



